Published In: Pharmaceutical Technology and BioPharm International
June 6, 2025
Matt Cushing, VP of Quality and Science, Nelson Labs, and Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, a Nelson Labs Company, discuss PDA/ANSI Standard 06-2025: Assessment of Quality Culture Guidance Documents, Models, and Tools, which was published in February 2025.
Learn more about the authors.
Pharmaceuticals Quality Assurance Expert
Susan has over 40 years of quality-assurance experience in the pharmaceutical industry. She has earned several awards from the Parenteral Drug Association (PDA), including Distinguished Author Award, Distinguished Service Award, and Gordon Personeus Award. Serving as a volunteer in a number of capacities, she has served on the PDA Board of Directors from 2011 to...
Vice President, Quality and Science
Matt Cushing is the Vice President of Quality and Science at Nelson Laboratories, where he oversees global initiatives and regulatory interactions for teams across 13 sites to uphold the company’s standards in quality, service, and science. With over 20 years of leadership experience in highly regulated environments, including GMP, GLP, ISO, FDA, and more — Matt brings a deep commitment to quality systems and people-centric leadership. His career at Nelson Labs spans roles from Quality Auditor to Senior Director and now Vice President, during which he has successfully managed global quality integration, high-risk scientific issues, and regulatory responses. Matt is known for building high-performing teams and mentoring future leaders, including facilitating leadership development programs, and participating in DEI and women's mentorship initiatives. A recipient of numerous academic and professional honors, including the President’s Award from the University of Utah and the 2025 Nelson Labs Inspired Mentorship Award — Matt continues to model values-driven leadership with a focus on service, collaboration, and continuous improvement.
